Compare Tata Nifty MidSmall Healthcare Index Fund vs UTI Healthcare Fund
Tata Nifty MidSmall Healthcare Index Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.14
2.22
NAV
₹14.47
₹364.62
Fund Started
08 Apr 2024
01 Aug 2005
Fund Size
₹220.69 Cr
₹1429.84 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year
10.32%
9.16%
3 Year
-
20.14%
5 Year
-
13.16%
Equity
100.14%
94.12%
Cash
-0.14%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Laurus Labs Ltd. | 11.84% |
Lupin Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 7.09% |
Fortis Healthcare Ltd. | 6.16% |
Glenmark Pharmaceuticals Ltd. | 5.40% |
Alkem Laboratories Ltd. | 4.78% |
Mankind Pharma Ltd. | 4.36% |
Ipca Laboratories Ltd. | 4.11% |
Biocon Ltd. | 3.96% |
Gland Pharma Ltd. | 3.55% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
08 Apr 2024
01 Aug 2005
